Spartalizumab
Showing 51 - 54 of 54
Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)
Completed
- Triple Negative Breast Cancer
- +3 more
-
Boston, Massachusetts
- +19 more
Jul 12, 2021
Hepatocellular Carcinoma (HCC), Solid Malignancies Trial in Worldwide (FGF401, PDR001)
Completed
- Hepatocellular Carcinoma (HCC)
- Solid Malignancies
- FGF401
- PDR001
-
Los Angeles, California
- +26 more
Nov 21, 2020